Ratios Revealed: Decoding Phreesia Inc (PHR)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The closing price of Phreesia Inc (NYSE: PHR) was $27.61 for the day, down -4.79% from the previous closing price of $29.00. In other words, the price has decreased by -$4.79 from its previous closing price. On the day, 0.65 million shares were traded. PHR stock price reached its highest trading level at $28.74 during the session, while it also had its lowest trading level at $27.53.

Ratios:

Our analysis of PHR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 68.99. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 08, 2025, Upgraded its rating to Outperform and sets its target price to $32 from $24 previously.

On February 26, 2024, Truist started tracking the stock assigning a Buy rating and target price of $35.

DA Davidson Upgraded its Neutral to Buy on January 17, 2024, whereas the target price for the stock was revised from $30 to $32.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 19 ’25 when Linetsky David sold 88 shares for $27.88 per share. The transaction valued at 2,454 led to the insider holds 8,724 shares of the business.

Linetsky David sold 39 shares of PHR for $1,051 on Mar 18 ’25. The SVP, Life Sciences now owns 8,812 shares after completing the transaction at $26.95 per share. On Mar 17 ’25, another insider, Hoffman Allison C, who serves as the General Counsel & Secretary of the company, sold 3,496 shares for $25.32 each. As a result, the insider received 88,519 and left with 139,134 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHR now has a Market Capitalization of 1622706048 and an Enterprise Value of 1195490304. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.87 while its Price-to-Book (P/B) ratio in mrq is 6.12. Its current Enterprise Value per Revenue stands at 2.848 whereas that against EBITDA is -33.739.

Stock Price History:

The Beta on a monthly basis for PHR is 0.77, which has changed by 0.19939184 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, PHR has reached a high of $30.53, while it has fallen to a 52-week low of $17.07. The 50-Day Moving Average of the stock is 1.23%, while the 200-Day Moving Average is calculated to be 17.76%.

Shares Statistics:

PHR traded an average of 433.64K shares per day over the past three months and 733600 shares per day over the past ten days. A total of 58.73M shares are outstanding, with a floating share count of 53.78M. Insiders hold about 8.50% of the company’s shares, while institutions hold 92.97% stake in the company. Shares short for PHR as of 1740700800 were 2063064 with a Short Ratio of 4.76, compared to 1738281600 on 2503873. Therefore, it implies a Short% of Shares Outstanding of 2063064 and a Short% of Float of 4.31.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Phreesia Inc (PHR).The consensus estimate for the next quarter is $0.19, with high estimates of $0.21 and low estimates of $0.17.

Analysts are recommending an EPS of between $0.92 and $0.86 for the fiscal current year, implying an average EPS of $0.89. EPS for the following year is $1.34, with 7.0 analysts recommending between $1.61 and $1.12.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 13 analysts. It ranges from a high estimate of $116.98M to a low estimate of $113.86M. As of the current estimate, Phreesia Inc’s year-ago sales were $101.22MFor the next quarter, 13 analysts are estimating revenue of $116.5M. There is a high estimate of $118.4M for the next quarter, whereas the lowest estimate is $115.4M.

A total of 15 analysts have provided revenue estimates for PHR’s current fiscal year. The highest revenue estimate was $480.67M, while the lowest revenue estimate was $475M, resulting in an average revenue estimate of $477.24M. In the same quarter a year ago, actual revenue was $419.81MBased on 13 analysts’ estimates, the company’s revenue will be $535.44M in the next fiscal year. The high estimate is $553.79M and the low estimate is $525M.

Most Popular